Cite

HARVARD Citation

    Chew, S. et al. (2021). SKAP2-BRAF fusion and response to an MEK inhibitor in a patient with metastatic melanoma resistant to immunotherapy. BMJ case reports. 14 (6), p. . [Online]. 
  
Back to record